Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cholesterol: Significance and Regulation01:29

Cholesterol: Significance and Regulation

Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...
Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The impact of climate change on psychiatric decompensation: A case report using the climate biopsychosocial framework.

The journal of climate change and health·2026
Same author

Beta-Adrenergic Stimulation and <i>MYH7</i> G256E Mutant Gene Dosage Drive Hypertrophic Cardiomyopathy Phenotype Penetrance.

bioRxiv : the preprint server for biology·2026
Same author

Progress in mast cell activation syndrome: the global consensus-2 diagnostic criteria at six years.

Diagnosis (Berlin, Germany)·2026
Same author

Python metabolomics uncovers a conserved postprandial metabolite and gut-brain feeding pathway.

Nature metabolism·2026
Same author

Cryo-ET reveals nanoscale thick filament disorganization in MYH7 P710R hypertrophic cardiomyopathy cardiomyocytes.

bioRxiv : the preprint server for biology·2026
Same author

Python metabolomics uncovers a conserved postprandial metabolite and gut-brain feeding pathway.

bioRxiv : the preprint server for biology·2026
Same journal

Images in Vascular Medicine: When coronary anatomy goes the wrong way-A diagnostic challenge.

Vascular medicine (London, England)·2026
Same journal

Home-based intravenous iloprost by portable elastomeric pump in chronic limb-threatening ischemia: A pilot study.

Vascular medicine (London, England)·2026
Same journal

Vascular Disease Patient Information Page: Renal denervation.

Vascular medicine (London, England)·2026
Same journal

Relations of Life's Essential 8 score with arterial and microvascular function: The Jackson Heart Study.

Vascular medicine (London, England)·2026
Same journal

Generalizability of the CREST‑2 trial: A real‑world analysis.

Vascular medicine (London, England)·2026
Same journal

Downhill-walking exercise training in a patient with symptomatic peripheral artery disease: A case report.

Vascular medicine (London, England)·2026
See all related articles

Related Experiment Video

Updated: Jun 21, 2026

A Murine Model of Hyperlipidemia&#45;Induced Heart Failure with Preserved Ejection Fraction
03:42

A Murine Model of Hyperlipidemia-Induced Heart Failure with Preserved Ejection Fraction

Published on: March 29, 2024

Hypercholesterolemia impairs exercise capacity in mice.

Andrew J Maxwell1, Josef Niebauer, Patrick S Lin

  • 1Division of Cardiovascular Medicine, Program in Vascular Medicine and Biology, Stanford University, Stanford, CA 94305-5246, USA.

Vascular Medicine (London, England)
|August 5, 2009
PubMed
Summary
This summary is machine-generated.

High cholesterol impairs aerobic exercise capacity in mice, linked to reduced nitric oxide production. Anaerobic capacity remains unaffected, highlighting a specific deficit in endurance performance.

More Related Videos

Quantification of Atherosclerosis in Mice
06:59

Quantification of Atherosclerosis in Mice

Published on: June 12, 2019

A Familial Hypercholesterolemia Human Liver Chimeric Mouse Model Using Induced Pluripotent Stem Cell-derived Hepatocytes
10:56

A Familial Hypercholesterolemia Human Liver Chimeric Mouse Model Using Induced Pluripotent Stem Cell-derived Hepatocytes

Published on: September 15, 2018

Related Experiment Videos

Last Updated: Jun 21, 2026

A Murine Model of Hyperlipidemia&#45;Induced Heart Failure with Preserved Ejection Fraction
03:42

A Murine Model of Hyperlipidemia-Induced Heart Failure with Preserved Ejection Fraction

Published on: March 29, 2024

Quantification of Atherosclerosis in Mice
06:59

Quantification of Atherosclerosis in Mice

Published on: June 12, 2019

A Familial Hypercholesterolemia Human Liver Chimeric Mouse Model Using Induced Pluripotent Stem Cell-derived Hepatocytes
10:56

A Familial Hypercholesterolemia Human Liver Chimeric Mouse Model Using Induced Pluripotent Stem Cell-derived Hepatocytes

Published on: September 15, 2018

Area of Science:

  • Cardiovascular Physiology
  • Metabolic Disorders
  • Exercise Science

Background:

  • Hypercholesterolemia is linked to cardiovascular dysfunction.
  • Previous studies indicated impaired exercise hyperemia and aerobic capacity in hypercholesterolemic mice.

Purpose of the Study:

  • To investigate the temporal and quantitative relationship between hypercholesterolemia and aerobic/anaerobic capacity.
  • To explore the mechanisms underlying exercise dysfunction in hypercholesterolemia.

Main Methods:

  • Utilized wild type and apoE knockout mice fed regular or high-fat diets to induce varying cholesterol levels.
  • Assessed exercise capacity using treadmill ergospirometry at different ages.
  • Measured aortic vasodilator function, nitric oxide (NOx) activity and excretion, muscle microvascular density, citrate synthase activity, and myocardial characteristics.

Main Results:

  • Aerobic exercise capacity progressively declined in hypercholesterolemic mice from 12 to 20 weeks of age.
  • Anaerobic capacity was unaffected by hypercholesterolemia.
  • Aerobic dysfunction correlated with serum cholesterol levels and was associated with reduced nitric oxide-mediated vascular function.

Conclusions:

  • Aerobic exercise dysfunction is evident in murine models of genetic and diet-induced hypercholesterolemia.
  • Reduced vascular nitric oxide production is a key mechanism associated with this aerobic exercise impairment.